Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)
Status: Open
Posted date: June 9, 2026
Archive date: January 8, 2027
Opportunity ID: 362731
Opportunity number: CDC-RFA-PS-27-0009
Opportunity category: Discretionary
Agency name: Centers for Disease Control - NCHHSTP
Agency code: HHS-CDC-NCHHSTP
Award floor: $0
Award ceiling: $0
Cost sharing required: No
Funding Instrument Types
- Cooperative Agreement
Category of Funding Activity
- Health
Eligible Applicants
- City or township governments
- County governments
- Others
- Special district governments
- State governments
Categories (use these for quoted searches)
- agency_code:hhs_cdc_nchhstp
- category_of_funding_activity:health
- cost_sharing_or_matching_requirement:false
- eligible_applicants:city_or_township_governments
- eligible_applicants:county_governments
- eligible_applicants:others
- eligible_applicants:special_district_governments
- eligible_applicants:state_governments
- funding_instrument_type:cooperative_agreement
- opportunity_category:discretionary
- status:open
This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings. This multi-component NOFO includes two required components and two optional components: Component 1: Outbreak Response and Surveillance (Required) Component 2: Planning, Partnerships, and Promotion (Required) Component 3: Testing, Treatment, and Prevention (Optional) Component 4: Perinatal Hepatitis C Program (Optional) This NOFO is alignment with CDC priorities.